SCHEMBL23115879

SCHEMBL23115879

CCOC(=O)c1cc(Br)cc2[nH]ncc12

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.51
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
METTL3 Q86U44 2/20 0.47
TDO2 P48775 4/20 0.47
SMN1; SMN2 Q16637 1/20 0.46
IDO1 P14902 4/20 0.45
GABRA1 P14867 2/20 0.45
GABRB2 P47870 2/20 0.45
GABRB1 P18505 1/20 0.45
GABRA3 P34903 1/20 0.45
KDM4E B2RXH2 2/20 0.43
PDE4B Q07343 1/20 0.41
MAPT P10636 1/20 0.41
JAK2 O60674 1/20 0.40
JAK3 P52333 1/20 0.40
EGFR P00533 1/20 0.40
ERBB2 P04626 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL459193 0.84 TDO2 (0.53) METTL3TDO2IDO1MAPT
SCHEMBL31158048 0.84 TDO2 (0.53) METTL3TDO2IDO1MAPT
SCHEMBL12118859 0.78 ALDH1A1 (0.51) ALDH1A1KMT2AMEN1SMN1; SMN2GABRA1
SCHEMBL459215 0.77 TDO2 (0.54) METTL3TDO2IDO1
SCHEMBL19100359 0.77 METTL3 (0.58) ALDH1A1KMT2AMEN1METTL3SMN1; SMN2
SCHEMBL28451309 0.76 TDO2 (0.52) TDO2IDO1
SCHEMBL458344 0.75 TDO2 (0.60) ALDH1A1METTL3TDO2IDO1KDM4E
SCHEMBL15655280 0.74 ALDH1A1 (0.71) ALDH1A1KMT2AMEN1SMN1; SMN2KDM4E
SCHEMBL1721973 0.73 CA12 (0.49) ALDH1A1KMT2AMEN1TDO2SMN1; SMN2
SCHEMBL3788064 0.73 MAPT (0.50) ALDH1A1KMT2AMEN1SMN1; SMN2KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12297190-B2 Modulators of STING (stimulator of interferon genes) PFIZER INC. (US) 2025-05-13 US disclosed
EP-4034534-A1 POLYHETEROCYCLIC MODULATORS OF STING (STIMULATOR OF INTERFERON GENES) Pfizer Inc. (US) 2022-08-03 EP disclosed
CN-114728946-A Polyheterocyclic modulators of STING (stimulator of interferon genes) 辉瑞公司 2022-07-08 CN disclosed
WO-2021059136-A1 POLYHETEROCYCLIC MODULATORS OF STING (STIMULATOR OF INTERFERON GENES) PFIZER INC. (US) 2021-04-01 WO disclosed
WO-2021059136-A1 POLYHETEROCYCLIC MODULATORS OF STING (STIMULATOR OF INTERFERON GENES) PFIZER INC. (US) 2021-04-01 WO disclosed
US-20210087180-A1 Modulators of STING (Stimulator of Interferon Genes) PFIZER INC. (US) 2021-03-25 US disclosed
US-20210087180-A1 Modulators of STING (Stimulator of Interferon Genes) PFIZER INC. (US) 2021-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12297190-B2 Modulators of STING (stimulator of interferon genes) STING1, IRF3, CGAS ALDH1A1 4800/4885KMT2A 4421/4885MEN1 2820/4885
US-20210087180-A1 Modulators of STING (Stimulator of Interferon Genes) STING1, IRF3, CGAS ALDH1A1 4800/4885KMT2A 4421/4885MEN1 2820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.